Immediate Impact

52 standout
Sub-graph 1 of 24

Citing Papers

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Screening for Breast Cancer
2024 Standout
2 intermediate papers

Works of Yung‐Feng Lo being referenced

Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis
2014
Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
2014

Author Peers

Author Last Decade Papers Cites
Yung‐Feng Lo 283 311 198 355 305 46 797
Donna Taylor 221 249 151 290 268 72 750
Selin Çarkaci 284 335 237 335 206 37 878
Eleanor Cornford 344 403 246 210 234 37 843
Hiroko Tsunoda 325 308 198 315 109 100 776
Paula B. Gordon 425 306 347 222 179 36 882
Stefanie Weigel 236 256 366 423 282 50 929
Fang‐I Lu 217 174 294 226 218 40 742
I. Schreer 481 373 177 382 105 47 882
Lucie Lalonde 487 240 211 296 157 39 952
Luca Alessandro Carbonaro 224 161 94 607 211 47 849

All Works

Loading papers...

Rankless by CCL
2026